Skip to content Skip to navigation

Recent News

Sep 18 2020 | Posted In: Announcements
Ten world-leading US, UK, and EU universities will discuss with leaders in national government and funding bodies on how to harness the enormous potential of research and commercialization for the urgent economic recovery in the wake of the COVID-19 pandemic. University researchers contributed to...
Sep 17 2020 | Endpoints News | Posted In: In the News
When Jim Broderick launched Massachusetts-based Palleon Pharmaceuticals in 2015, he had an office in Cambridge’s Kendall Square, a bit of seed money, and a blank canvas. He set out to innovate within a new space in immunology, and recruited scientific co-founders Carolyn Bertozzi, a Stanford...
Sep 17 2020 | Endpoints News | Posted In: In the News
Debanjan Ray apparently had big plans when he quietly left his long-held CFO spot at CytomX back in March 2019. He had gotten his own biotech. Still in its early stages at the time, that biotech, known as Synthekine, is now ready to start talking. They are breaking out of stealth mode today with...
Sep 16 2020 | BUSINESS WIRE | Posted In: In the News
Next-generation gene editing company launched by Versant Ventures with additional backing by Samsara BioCapital Core technology from Stanford founders Matt Porteus and Maria Grazia Roncarolo Josh Lehrer joins as CEO
Sep 8 2020 | SF Business Times
A Spanish health care company at the forefront of turning plasma against Covid-19 will buy out a Stanford University spinout focused on age-defying proteins from the clear, yellowish liquid portion of blood. Grifols S.A. (NASDAQ: GRFS) said it will buy the rest of Alkahest Inc. that it didn't...

Pages